Type 1 diabetes mellitus with proliferative diabetic retinopathy
ICD-10 E10.35 is a billable code used to indicate a diagnosis of type 1 diabetes mellitus with proliferative diabetic retinopathy.
E10.35 refers to Type 1 diabetes mellitus characterized by the presence of proliferative diabetic retinopathy (PDR), a severe complication of diabetes that affects the retina. PDR occurs when new, abnormal blood vessels grow on the surface of the retina, which can lead to vision loss and blindness. This condition is typically a result of chronic hyperglycemia, which damages the retinal blood vessels over time. Patients with Type 1 diabetes often require insulin therapy to manage their blood glucose levels effectively. The management of diabetes includes regular monitoring of HbA1c levels, which should ideally be maintained below 7% to reduce the risk of complications such as PDR. The presence of PDR indicates a significant progression of diabetic eye disease, necessitating close monitoring and potential interventions such as laser therapy or vitrectomy. Accurate coding of E10.35 is crucial for appropriate treatment planning and reimbursement, as it reflects the severity of the patient's condition and the need for specialized care.
Detailed retinal examination findings, including the presence and extent of proliferative changes.
Patients presenting with vision changes or diabetic eye disease requiring intervention.
Ensure documentation reflects the severity of retinopathy and any treatments provided.
Comprehensive diabetes management plans, including insulin regimens and HbA1c monitoring.
Patients with poorly controlled diabetes and complications requiring insulin adjustments.
Document all aspects of diabetes management to support coding and reimbursement.
Used for patients with proliferative diabetic retinopathy requiring intervention.
Document the indication for the procedure and any pre-operative assessments.
Ophthalmology should ensure that all findings are documented to support the procedure.
Coding E10.35 accurately reflects the severity of a patient's diabetes and associated complications, which is crucial for appropriate management and reimbursement.
